Utility of Screening Tools to Differentiate Beta Thalassemia Trait and Iron-deficiency Anemia - Do They Serve a Purpose in Blood Donors?

Overview

Journal Blood Res

Publisher Springer Nature

Specialty Hematology

Date 2020 Sep 29

PMID 32989178

Citations 4

Authors

Amanpreet Sundh

Paramjit Kaur

Anshu Palta

Gagandeep Kaur

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to estimate the prevalence of the beta thalassemia trait (BTT) and differentiate it from iron-deficiency anemia (IDA) among blood donors.

Methods: A total of 1,000 samples from blood donors were subjected to complete hemogram with red blood cell indices. Further, Mentzer index (MI) was calculated for samples with mean corpuscular volume (MCV) below 80 fL and mean corpuscular hemoglobin (MCH) below 27 pg. Samples with Mentzer index ＜12 were subjected to naked-eye single-tube red cell osmotic fragility test (NESTROFT) followed by hemoglobin electrophoresis in positive cases. Serum ferritin was assessed in NESTROFT-negative cases.

Results: The prevalence of BTT among blood donors was 3.7% and that of microcytosis among donors was 8.6%. The prevalence of BTT among microcytic donors was 41.8% while that among those with IDA was 11.6%. A value of MI ＜13 was highly sensitive in the diagnosis of BTT. MI ＞13 was found to have both high specificity and high sensitivity for diagnosing IDA.

Conclusion: A moderately high prevalence of BTT was observed among blood donors. Presently, no screening program is mandatory for screening of BTT among blood donors. Indices like MCV, MCH, and Mentzer Index were thus found to be effective to screen for BTT and IDA among blood donors, and NESTROFT was a cost-effective mass screening method to differentiate BTT and IDA.

Citing Articles

A study to assess the occurrence of anaemia and beta-thalassemia in the tribal population residing in the Yadadri-Bhuvanagiri district of Telangana state.

Patil P, Kusneniwar G, Rathod G, Pradeep I, Prabhala S, Pyati A J Family Med Prim Care. 2024; 13(10):4611-4615.

PMID: 39629449 PMC: 11610892. DOI: 10.4103/jfmpc.jfmpc_553_24.

Lead (Pb) and cadmium (Cd) blood levels and potential hematological health risk among inhabitants of the claimed hazardous region around Qaroun Lake in Egypt.

Bakr S, Sayed M, Salem K, Morsi E, Masoud M, Ezzat E BMC Public Health. 2023; 23(1):1071.

PMID: 37277752 PMC: 10240759. DOI: 10.1186/s12889-023-16007-w.

Role of Mentzer index for differentiating iron deficiency anemia and beta thalassemia trait in pregnant women.

Tabassum S, Khakwani M, Fayyaz A, Taj N Pak J Med Sci. 2022; 38(4Part-II):878-882.

PMID: 35634613 PMC: 9121960. DOI: 10.12669/pjms.38.4.4635.

Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality.

Hadjesfandiari N, Khorshidfar M, Devine D Int J Mol Sci. 2021; 22(8).

PMID: 33920459 PMC: 8069744. DOI: 10.3390/ijms22083943.

References

Madan N, Sharma S, Sood S, Colah R, Bhatia L . Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010; 16(1):16-25. PMC: 2927789. DOI: 10.4103/0971-6866.64941. View

Mondal S, Mandal S . Prevalence of thalassemia and hemoglobinopathy in eastern India: A 10-year high-performance liquid chromatography study of 119,336 cases. Asian J Transfus Sci. 2016; 10(1):105-10. PMC: 4782486. DOI: 10.4103/0973-6247.175424. View

Verma I, Saxena R, Kohli S . Past, present & future scenario of thalassaemic care & control in India. Indian J Med Res. 2011; 134:507-21. PMC: 3237251. View

Vichinsky E . Changing patterns of thalassemia worldwide. Ann N Y Acad Sci. 2005; 1054:18-24. DOI: 10.1196/annals.1345.003. View

Flint J, Harding R, Boyce A, Clegg J . The population genetics of the haemoglobinopathies. Baillieres Clin Haematol. 2000; 11(1):1-51. DOI: 10.1016/s0950-3536(98)80069-3. View

Rosline H, Ahmed S, Al-Joudi F, Rapiaah M, Naing N, Adam N . Thalassemia among blood donors at the Hospital Universiti Sains Malaysia. Southeast Asian J Trop Med Public Health. 2006; 37(3):549-52. View

Tiwari A, Chandola I . Comparing prevalence of Iron Deficiency Anemia and Beta Thalassemia Trait in microcytic and non-microcytic blood donors: suggested algorithm for donor screening. Asian J Transfus Sci. 2010; 3(2):99-102. PMC: 2920481. DOI: 10.4103/0973-6247.53883. View

Mehta B, Dave V, Joshi S, BAXI A, Bhatia H, Patel J . Study of hematological and genetical characteristics of Cutchhi Bhanushali community. Indian J Med Res. 1972; 60(2):305-11. View

Tiwari A, Chandola I, Ahuja A . Approach to blood donors with microcytosis. Transfus Med. 2009; 20(2):88-94. DOI: 10.1111/j.1365-3148.2009.00980.x. View

10.

Modell B, Darlison M . Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008; 86(6):480-7. PMC: 2647473. DOI: 10.2471/blt.06.036673. View

11.

Kulkarni P, Masthi N, Niveditha S, Suvarna R . The Prevalence of the Beta Thalassemia Trait among the Pregnant Women who attended the ANC Clinic in a PHC, by using the NESTROF Test in Bangalore, Karnataka. J Clin Diagn Res. 2013; 7(7):1414-7. PMC: 3749648. DOI: 10.7860/JCDR/2013/5286.3149. View

12.

Kattamis C, EFREMOV G, Pootrakul S . Effectiveness of one tube osmotic fragility screening in detecting beta-thalassaemia trait. J Med Genet. 1981; 18(4):266-70. PMC: 1048730. DOI: 10.1136/jmg.18.4.266. View

13.

Chatterjee N, Mishra A, Soni R, Kulkarni H, Mamtani M, Shrivasatava M . Bayesian estimates of the prevalence of β-thalassemia trait in voluntary blood donors of central India: a survey. Hemoglobin. 2010; 34(6):548-60. DOI: 10.3109/03630269.2010.526488. View

14.

Mohanty D, Colah R, Gorakshakar A, Patel R, Master D, Mahanta J . Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Community Genet. 2012; 4(1):33-42. PMC: 3537975. DOI: 10.1007/s12687-012-0114-0. View